SCHEMBL27744643

SCHEMBL27744643

CC(c1ccccc1)C(F)(F)F.O=S(=O)(Cl)Cl

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GMNN O75496 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
PMP22 Q01453 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA5A P35218 1/20 0.35
CA9 Q16790 1/20 0.35
MEN1 O00255 1/20 0.35
TSHR P16473 1/20 0.34
SRC P12931 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1416399 0.87 TAAR1 (0.41) ALDH1A1KDM4ELMNA
SCHEMBL8090925 0.87 TAAR1 (0.41) ALDH1A1KDM4ELMNA
SCHEMBL13852044 0.87 TAAR1 (0.41) ALDH1A1KDM4ELMNA
Hydrogen Sulfide SCHEMBL27744648 0.85 TAAR1 (0.39) ALDH1A1KDM4ELMNA
SCHEMBL1030405 0.78 ALDH1A1 (0.40) ALDH1A1TDP1KDM4ELMNAMAPT
Isopropylbenzene SCHEMBL1416132 0.76 ALDH1A1 (0.44) ALDH1A1TDP1KMT2AKDM4EGMNN
SCHEMBL19706344 0.75 PTGS2 (0.48) ALDH1A1
SCHEMBL27764530 0.73 ALDH1A1 (0.38) ALDH1A1TDP1KMT2AMAPTNPSR1
SCHEMBL9475159 0.72 CES2 (0.41) ALDH1A1TDP1KMT2AKDM4EGMNN
SCHEMBL27680631 0.72 AOC3 (0.47) ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101421243-B Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor ABBOTT GMBH & CO KG 2012-05-30 CN disclosed
CN-101421243-A Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor ABBOTT GMBH & CO KG (DE) 2009-04-29 CN disclosed